000155732 001__ 155732
000155732 005__ 20240209160645.0
000155732 0247_ $$2doi$$a10.1016/j.neurobiolaging.2021.03.003
000155732 0247_ $$2pmid$$apmid:33845399
000155732 0247_ $$2ISSN$$a0197-4580
000155732 0247_ $$2ISSN$$a1558-1497
000155732 0247_ $$2altmetric$$aaltmetric:101654759
000155732 037__ $$aDZNE-2021-00900
000155732 041__ $$aEnglish
000155732 082__ $$a610
000155732 1001_ $$aBabiloni, Claudio$$b0
000155732 245__ $$aEEG measures for clinical research in major vascular cognitive impairment: recommendations by an expert panel.
000155732 260__ $$aAmsterdam [u.a.]$$bElsevier Science$$c2021
000155732 3367_ $$2DRIVER$$aarticle
000155732 3367_ $$2DataCite$$aOutput Types/Journal article
000155732 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1707491159_2406$$xReview Article
000155732 3367_ $$2BibTeX$$aARTICLE
000155732 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000155732 3367_ $$00$$2EndNote$$aJournal Article
000155732 520__ $$aVascular contribution to cognitive impairment (VCI) and dementia is related to etiologies that may affect the neurophysiological mechanisms regulating brain arousal and generating electroencephalographic (EEG) activity. A multidisciplinary expert panel reviewed the clinical literature and reached consensus about the EEG measures consistently found as abnormal in VCI patients with dementia. As compared to cognitively unimpaired individuals, those VCI patients showed (1) smaller amplitude of resting state alpha (8-12 Hz) rhythms dominant in posterior regions; (2) widespread increases in amplitude of delta (< 4 Hz) and theta (4-8 Hz) rhythms; and (3) delayed N200/P300 peak latencies in averaged event-related potentials, especially during the detection of auditory rare target stimuli requiring participants' responses in 'oddball' paradigms. The expert panel formulated the following recommendations: (1) the above EEG measures are not specific for VCI and should not be used for its diagnosis; (2) they may be considered as 'neural synchronization' biomarkers to enlighten the relationships between features of the VCI-related cerebrovascular lesions and abnormalities in neurophysiological brain mechanisms; and (3) they may be tested in future clinical trials as prognostic biomarkers and endpoints of interventions aimed at normalizing background brain excitability and vigilance in wakefulness.
000155732 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000155732 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000155732 650_7 $$2Other$$aCerebrovascular disease (CVD)
000155732 650_7 $$2Other$$aEvent-related oscillations (EROs)
000155732 650_7 $$2Other$$aEvent-related potentials (ERPs)
000155732 650_7 $$2Other$$aResting state electroencephalographic (rsEEG) rhythms
000155732 650_7 $$2Other$$aSmall vessel disease
000155732 650_7 $$2Other$$aSubcortical ischemic vascular disease
000155732 650_7 $$2Other$$aVascular cognitive impairment (VCI)
000155732 650_7 $$2Other$$aVascular contribution to cognitive impairment and dementia (VCID)
000155732 650_7 $$2Other$$aVascular dementia (VaD)
000155732 650_2 $$2MeSH$$aBrain: physiopathology
000155732 650_2 $$2MeSH$$aCognitive Dysfunction: diagnosis
000155732 650_2 $$2MeSH$$aCognitive Dysfunction: etiology
000155732 650_2 $$2MeSH$$aCognitive Dysfunction: physiopathology
000155732 650_2 $$2MeSH$$aDementia, Vascular: diagnosis
000155732 650_2 $$2MeSH$$aDementia, Vascular: etiology
000155732 650_2 $$2MeSH$$aDementia, Vascular: physiopathology
000155732 650_2 $$2MeSH$$aElectroencephalography: methods
000155732 650_2 $$2MeSH$$aEvoked Potentials: physiology
000155732 650_2 $$2MeSH$$aHumans
000155732 650_2 $$2MeSH$$aRest: physiology
000155732 7001_ $$aArakaki, Xianghong$$b1
000155732 7001_ $$aBonanni, Laura$$b2
000155732 7001_ $$aBujan, Ana$$b3
000155732 7001_ $$aCarrillo, Maria C$$b4
000155732 7001_ $$aDel Percio, Claudio$$b5
000155732 7001_ $$aEdelmayer, Rebecca M$$b6
000155732 7001_ $$aEgan, Gary$$b7
000155732 7001_ $$aElahh, Fanny M$$b8
000155732 7001_ $$aEvans, Alan$$b9
000155732 7001_ $$aFerri, Raffaele$$b10
000155732 7001_ $$0P:(DE-2719)9001538$$aFrisoni, Giovanni B$$b11$$udzne
000155732 7001_ $$aGüntekin, Bahar$$b12
000155732 7001_ $$aHainsworth, Atticus$$b13
000155732 7001_ $$aHampel, Harald$$b14
000155732 7001_ $$aJelic, Vesna$$b15
000155732 7001_ $$aJeong, Jaeseung$$b16
000155732 7001_ $$aKim, Doh Kwan$$b17
000155732 7001_ $$aKramberger, Milica$$b18
000155732 7001_ $$aKumar, Sanjeev$$b19
000155732 7001_ $$aLizio, Roberta$$b20
000155732 7001_ $$aNobili, Flavio$$b21
000155732 7001_ $$aNoce, Giuseppe$$b22
000155732 7001_ $$aPuce, Aina$$b23
000155732 7001_ $$aRitter, Petra$$b24
000155732 7001_ $$aSmit, Dirk J A$$b25
000155732 7001_ $$aSoricelli, Andrea$$b26
000155732 7001_ $$0P:(DE-2719)2000026$$aTeipel, Stefan$$b27$$udzne
000155732 7001_ $$aTucci, Federico$$b28
000155732 7001_ $$aSachdev, Perminder$$b29
000155732 7001_ $$aValdes-Sosa, Mitchell$$b30
000155732 7001_ $$aValdes-Sosa, Pedro$$b31
000155732 7001_ $$aVergallo, Andrea$$b32
000155732 7001_ $$aYener, Görsev$$b33
000155732 773__ $$0PERI:(DE-600)1498414-3$$a10.1016/j.neurobiolaging.2021.03.003$$gVol. 103, p. 78 - 97$$p78 - 97$$tNeurobiology of aging$$v103$$x0197-4580$$y2021
000155732 8564_ $$uhttps://pub.dzne.de/record/155732/files/DZNE-2021-00900_Restricted.pdf
000155732 8564_ $$uhttps://pub.dzne.de/record/155732/files/DZNE-2021-00900_Restricted.pdf?subformat=pdfa$$xpdfa
000155732 909CO $$ooai:pub.dzne.de:155732$$pVDB
000155732 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9001538$$aExternal Institute$$b11$$kExtern
000155732 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000026$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b27$$kDZNE
000155732 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000155732 9141_ $$y2021
000155732 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000155732 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000155732 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000155732 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2022-11-10$$wger
000155732 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNEUROBIOL AGING : 2021$$d2022-11-10
000155732 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-10
000155732 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-10
000155732 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-10
000155732 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-10
000155732 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-10
000155732 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-10
000155732 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-10
000155732 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-10
000155732 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNEUROBIOL AGING : 2021$$d2022-11-10
000155732 9201_ $$0I:(DE-2719)1510100$$kAG Teipel$$lClinical Dementia Research (Rostock /Greifswald)$$x0
000155732 980__ $$ajournal
000155732 980__ $$aVDB
000155732 980__ $$aI:(DE-2719)1510100
000155732 980__ $$aUNRESTRICTED